Jump to: Page Content, Site Navigation, Site Search,
You are seeing this message because your web browser does not support basic web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.
BMJ 2008;336:974 (3 May), doi:10.1136/bmj.39563.442407.80
| The first 150 words of the full text of this article appear below. |
Brearley cites the US Preventive Services Task Force (USPSTF) in support of abdominal aortic aneurysm screening.1 However, it makes no recommendation for or against screening in men aged 65-75 who have never smoked. The task force did find good evidence that screening in these men leads to decreased abdominal aortic aneurysm specific mortality, but they have a lower prevalence of large abdominal aortic aneurysms than men who have ever smoked, so the potential benefit is small. There is good evidence that screening and early treatment lead to important harms, including increased number of operations with associated clinically significant morbidity and mortality, and short term psychological harm. The task force concluded that the balance between the benefits and harms of screening for abdominal aortic aneurysm is too close to make a general recommendation in this population.2
The men invited for screening should be given this information as well as the likelihood
John Doherty, medical director
1 IAEA, Vienna, Austria 1400
j.doherty@iaea.org